PamGene International is to combine its microarray platform with
Jerini Peptide Technologies' (JPT) peptide libraries to create a
series of new products for kinase studies.
Companies developing new drugs for the global market must deal with
the rising costs of the R&D process - and outsourcing may well
be the best route, according to Dr Faiz Kermani, a specialist in
outsourcing and research development.
Despite a dip in the fortunes of the biotechnology industry,
bioinformatics firm BlueGnome has achieved profit in less than
three years since its formation. The firm's fortunes are in
contrast to similar start up firms within...
International R&D group SRI has set up a new company to harvest
the growing number of new therapeutic agents in development at
bioresearch laboratories in Asia.
A clear legal basis has been established for the first time which
will enable research institutions to use molecular biology
techniques for which provate companies have dominant patent
positions without signing away the rights to...
